BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3887857)

  • 1. The canine transmissible venereal tumor: a unique result of tumor progression.
    Cohen D
    Adv Cancer Res; 1985; 43():75-112. PubMed ID: 3887857
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor size, leukocyte adherence inhibition and serum levels of tumor antigen in dogs with the canine transmissible venereal sarcoma.
    Yang TJ; Palker TJ; Harding MW
    Cancer Immunol Immunother; 1991; 33(4):255-62. PubMed ID: 2059969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of leukocyte glass adherence and tube leukocyte adherence inhibition (LAI) reactivity by serum factors in dogs with progressing or spontaneously regressing canine transmissible venereal sarcoma (CTVS).
    Harding MW; Yang TJ
    Cancer Immunol Immunother; 1985; 19(3):168-76. PubMed ID: 3891077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of beta 2-microglobulin on the surface of canine transmissible venereal tumor cells.
    Cohen D; Shalev A; Krup M
    J Natl Cancer Inst; 1984 Feb; 72(2):395-401. PubMed ID: 6363791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth stage dependent expression of MHC antigens on the canine transmissible venereal sarcoma.
    Yang TJ; Chandler JP; Dunne-Anway S
    Br J Cancer; 1987 Feb; 55(2):131-4. PubMed ID: 2949770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmission of transmissible venereal tumor of the dog to the coyote.
    Cockrill JM; Beasley JN
    Am J Vet Res; 1979 Mar; 40(3):409-10. PubMed ID: 475096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence of the acquired immunity in early vertebrates due to danger of transmissible cancers similar to canine venereal tumors.
    Kurbel S; Plestina S; Vrbanec D
    Med Hypotheses; 2007; 68(5):1185-6. PubMed ID: 17110053
    [No Abstract]   [Full Text] [Related]  

  • 8. Canine transmissible venereal tumour: cytogenetic origin, immunophenotype, and immunobiology. A review.
    Mukaratirwa S; Gruys E
    Vet Q; 2003 Sep; 25(3):101-11. PubMed ID: 14535580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential changes in peripheral blood leukocyte adherence inhibition (LAI) reactivity during progressive growth and spontaneous regression of canine transmissible venereal sarcoma.
    Harding MW; Yang TJ
    Int J Cancer; 1981 Sep; 28(3):361-6. PubMed ID: 7319678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmissible venereal neoplasia.
    Yang TJ
    Am J Obstet Gynecol; 1981 Apr; 139(8):979-80. PubMed ID: 7223806
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunoelectron microscopic localization of a tumor-associated antigen (TAA) in the canine transmissible venereal sarcoma by anti-TAA-antiferritin hybrid antibodies.
    Hill DL; Yang TJ
    J Natl Cancer Inst; 1985 Oct; 75(4):725-32. PubMed ID: 3900513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of MHC expression and retention of ultrastructural characteristics by xenograft transmissible venereal tumor cells in SCID mice.
    Harmelin A; Pinthus JH; Friedmann-Morvinski D; Kaufman K; Brenner O
    Vet Immunol Immunopathol; 2002 Jul; 86(3-4):245-9. PubMed ID: 12007890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro cell-mediated cytotoxicity and antibody-dependent cellular cytotoxicity to the transmissible venereal tumor of the dog.
    Cohen D
    J Natl Cancer Inst; 1980 Feb; 64(2):317-21. PubMed ID: 6928223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canine Transmissible Venereal Tumor: Is Its Biological Behavior Changing?
    Duzanski AP; Fêo HB; Montoya LM; Seullner CV; Rocha NS
    Anat Rec (Hoboken); 2017 Jun; 300(6):1009-1010. PubMed ID: 27981811
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunotherapy for the treatment of canine transmissible venereal tumor based in dendritic cells pulsed with tumoral exosomes.
    Ramos-Zayas Y; Franco-Molina MA; Hernádez-Granados AJ; Zárate-Triviño DG; Coronado-Cerda EE; Mendoza-Gamboa E; Zapata-Benavides P; Ramírez-Romero R; Santana-Krymskaya SE; Tamez-Guerra R; Rodríguez-Padilla C
    Immunopharmacol Immunotoxicol; 2019 Feb; 41(1):48-54. PubMed ID: 30334465
    [No Abstract]   [Full Text] [Related]  

  • 16. Canine transmissible venereal tumor (TVT): a review.
    Vermooten MI
    J S Afr Vet Assoc; 1987 Sep; 58(3):147-50. PubMed ID: 3334057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canine transmissible venereal sarcoma: leukocyte adherence inhibition (LAI) reactivity of various lymphoid tissues of dogs with tumors at different stages of growth.
    Harding MW; Yang TJ
    Int J Cancer; 1981 Mar; 27(3):349-55. PubMed ID: 7026460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histological and Ultrastructural findings of regressing canine transmissible venereal tumor after repeated transplantation.
    Otomo K; Koike T; Kudo T; Sakai T
    Nihon Juigaku Zasshi; 1981 Dec; 43(6):823-32. PubMed ID: 7343693
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunophenotype of the canine transmissible venereal tumour.
    Marchal T; Chabanne L; Kaplanski C; Rigal D; Magnol JP
    Vet Immunol Immunopathol; 1997 Jun; 57(1-2):1-11. PubMed ID: 9239833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer biology: infectious tumour cells.
    Dingli D; Nowak MA
    Nature; 2006 Sep; 443(7107):35-6. PubMed ID: 16957717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.